Cargando…

Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer

Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs)...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hailiu, Obiora, Daisy, Tomaszewski, Jeffrey J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185654/
https://www.ncbi.nlm.nih.gov/pubmed/34159101
http://dx.doi.org/10.21037/tau.2020.03.14
_version_ 1783704829062807552
author Yang, Hailiu
Obiora, Daisy
Tomaszewski, Jeffrey J.
author_facet Yang, Hailiu
Obiora, Daisy
Tomaszewski, Jeffrey J.
author_sort Yang, Hailiu
collection PubMed
description Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs) via a minimally invasive approach. The robot offers multiple potential advantages such as smaller incisions, improved 3D visualization, more precise dissection, and faster convalescence, leading to its increased usage the past several years. In this chapter, we summarize the recent progress made in robotic surgery for testicular cancer and its potential in the future. Promising preliminary data has also renewed interest in defining the role of primary RPLND in patients with seminoma, potentially sparing patients of the harmful long-term radiation and cisplatin-based chemotherapy. SEMS and PRIMETEST trials are ongoing trials that will provide significant insight into this area and potentially expand the role of robotic RPLND.
format Online
Article
Text
id pubmed-8185654
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-81856542021-06-21 Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer Yang, Hailiu Obiora, Daisy Tomaszewski, Jeffrey J. Transl Androl Urol Review Article on Controversies in Minimally Invasive Urologic Oncology Treatment of testicular cancer has made significant progress in the past decades in terms of reduction of treatment-associated morbidity and preventing over-treatment. At the forefront of this progression is utilization of the da Vinci robot to perform retroperitoneal lymph node dissections (RPLNDs) via a minimally invasive approach. The robot offers multiple potential advantages such as smaller incisions, improved 3D visualization, more precise dissection, and faster convalescence, leading to its increased usage the past several years. In this chapter, we summarize the recent progress made in robotic surgery for testicular cancer and its potential in the future. Promising preliminary data has also renewed interest in defining the role of primary RPLND in patients with seminoma, potentially sparing patients of the harmful long-term radiation and cisplatin-based chemotherapy. SEMS and PRIMETEST trials are ongoing trials that will provide significant insight into this area and potentially expand the role of robotic RPLND. AME Publishing Company 2021-05 /pmc/articles/PMC8185654/ /pubmed/34159101 http://dx.doi.org/10.21037/tau.2020.03.14 Text en 2021 Translational Andrology and Urology. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Review Article on Controversies in Minimally Invasive Urologic Oncology
Yang, Hailiu
Obiora, Daisy
Tomaszewski, Jeffrey J.
Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title_full Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title_fullStr Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title_full_unstemmed Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title_short Outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
title_sort outcomes and expanding indications for robotic retroperitoneal lymph node dissection for testicular cancer
topic Review Article on Controversies in Minimally Invasive Urologic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8185654/
https://www.ncbi.nlm.nih.gov/pubmed/34159101
http://dx.doi.org/10.21037/tau.2020.03.14
work_keys_str_mv AT yanghailiu outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer
AT obioradaisy outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer
AT tomaszewskijeffreyj outcomesandexpandingindicationsforroboticretroperitoneallymphnodedissectionfortesticularcancer